Fosabelogo (Fosabelogo)
Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 71839-104
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 71839-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Be Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fosacartonlabel (Fosacartonlabel)
This text appears to describe a medication called Fosaprepitant, which is available in a 150mg vial for injection. The medication should only be used intravenously after reconstitution and it contains sodium. The recommended dosage and administration instructions are not fully available due to the poor quality of the text. The manufacturer's name and address are also not readable.*
Fosalogo (Fosalogo)
Fosastr (Fosastr)
Fosaviallabel (Fosaviallabel)
M.L. No.: 13/MDCHL/TS/2017/B&F/G is a product distributed by BE Pharmaceuticals Inc., made in India, with National Drug Code 71839-104-01. The rest of the text is not-available or not readable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
